GEN1078
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEN1078, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors [Phase 1, Phase 2]